GENFIT - ALGFT - FR0004163111

Beleggen in aandelen beurzen Frankfurt DAX, Londen FTSE 100, Parijs CAC40
Stofke
Premiummember
Premiummember
Berichten: 622
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 321
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 31 Jan 2019 21:20

Genfit And Elafibranor In NASH Fibrosis: The FDA Guidelines For Conditional Approval

https://seekingalpha.com/amp/article/42 ... ssion=true



Word gratis lid op Beursig.com

Discussieer met duizenden beleggers en profiteer
van minder advertenties en abonneer op onderwerpen.

Registreer nu binnen enkele tellen



powered by Surfing Waves

Stofke
Premiummember
Premiummember
Berichten: 622
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 321
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 18 Feb 2019 11:10

ZGlobal NASH Congress
February 25-26, 2019
London

http://www.global-engage.com/event/nash/

Stofke
Premiummember
Premiummember
Berichten: 622
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 321
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 24 Feb 2019 17:46

Most NASH biotechs are years behind, but there is a good chance for Genfit (OTCPK:GNFTF) to capitalize where Intercept failed.

https://seekingalpha.com/amp/article/42 ... ssion=true

Stofke
Premiummember
Premiummember
Berichten: 622
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 321
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 26 Feb 2019 18:51

Nonalcoholic Steatohepatitis Therapeutics Market will Cross US$20.27 bn by 2025

https://honestversion.com/nonalcoholic- ... n-by-2025/

Stofke
Premiummember
Premiummember
Berichten: 622
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 321
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 27 Feb 2019 22:06

Genfit kondigt de indiening aan van een registratiedocument voor de geplande beursintroductie in de Verenigde Staten

https://www.genfit.com/press-release/ge ... ed-states/

Stofke
Premiummember
Premiummember
Berichten: 622
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 321
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 03 Mar 2019 10:26

Genfit May Become Very Interesting By The End Of 2019

https://seekingalpha.com/amp/article/42 ... ssion=true

Stofke
Premiummember
Premiummember
Berichten: 622
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 321
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 06 Mar 2019 16:37

Elafibranor interrupts adipose dysfunction-mediated gut and liver injury in mice with alcoholic steatohepatitis

http://www.clinsci.org/content/133/3/531

Stofke
Premiummember
Premiummember
Berichten: 622
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 321
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 11 Mar 2019 08:24

GENFIT announces FDA Protocol Clearance for Phase 2 Clinical Trial of Elafibranor in Pediatric NASH

https://www.genfit.com/press-release/ge ... tric-nash/

BDM Holding
Forum newbie
Forum newbie
Berichten: 10
Lid geworden op: 24 Jan 2019 11:09
waarderingen: 2
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor BDM Holding » 14 Mar 2019 20:06

GENFIT announces Launch of Proposed Global Offering and Nasdaq listing

https://www.genfit.com/press-release/ge ... q-listing/

Stofke
Premiummember
Premiummember
Berichten: 622
Lid geworden op: 13 Okt 2017 16:18
waarderingen: 321
Contact:

Re: GENFIT - ALGFT - FR0004163111

Berichtdoor Stofke » 14 Mar 2019 22:05

#PressRelease GENFIT announces Launch of Proposed Global Offering and Nasdaq listing

https://www.genfit.com/press-release/ge ... q-listing/